Neurotechnology for Pain

被引:5
|
作者
Fisher, Lee E. [1 ,2 ,3 ]
Lempka, Scott F. [4 ,5 ]
机构
[1] Univ Pittsburgh, Dept Phys Med & Rehabil, Rehab Neural Engn Labs, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA
[3] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA
[4] Univ Michigan, Dept Biomed Engn, Biointerfaces Inst, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA
关键词
chronic pain; deep brain stimulation; pain management; peripheral nervous system; spinal cord stimulation; transcutaneous electric nerve stimulation; SPINAL-CORD STIMULATION; DEEP BRAIN-STIMULATION; MOTOR CORTEX STIMULATION; DORSAL-ROOT GANGLION; CHRONIC NEUROPATHIC PAIN; LOW-BACK-PAIN; KILOHERTZ-FREQUENCY; NERVE-STIMULATION; CONDUCTION BLOCK; INTRACTABLE PAIN;
D O I
10.1146/annurev-bioeng-111022-121637
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Neurotechnologies for treating pain rely on electrical stimulation of the central or peripheral nervous system to disrupt or block pain signaling and have been commercialized to treat a variety of pain conditions. While their adoption is accelerating, neurotechnologies are still frequently viewed as a last resort, after many other treatment options have been explored.We review the pain conditions commonly treated with electrical stimulation, as well as the specific neurotechnologies used for treating those conditions. We identify barriers to adoption, including a limited understanding of mechanisms of action, inconsistent efficacy across patients, and challenges related to selectivity of stimulation and off-target side effects. We describe design improvements that have recently been implemented, as well as some cutting-edge technologies that may address the limitations of existing neurotechnologies. Addressing these challenges will accelerate adoption and change neurotechnologies from last-line to first-line treatments for people living with chronic pain.
引用
收藏
页码:387 / 412
页数:26
相关论文
共 50 条
  • [41] WONOEP 2022: Neurotechnology for the diagnosis of epilepsy
    Wagstyl, Konrad
    Kobow, Katja
    Casillas-Espinosa, Pablo M.
    Cole, Andrew J.
    Jimenez-Jimenez, Diego
    Nariai, Hiroki
    Baulac, Stephanie
    O'Brien, Terence
    Henshall, David C.
    Akman, Ozlem
    Sankar, Raman
    Galanopoulou, Aristea S.
    Auvin, Stephane
    EPILEPSIA, 2024, 65 (08) : 2238 - 2247
  • [42] Does Neurotechnology Produce a Better Brain?
    Bhattacharyya, Rajan
    Coffman, Brian A.
    Choe, Jaehoon
    Phillips, Matthew E.
    COMPUTER, 2017, 50 (02) : 48 - 58
  • [43] Advocating for neurodata privacy and neurotechnology regulation
    Rafael Yuste
    Nature Protocols, 2023, 18 : 2869 - 2875
  • [44] Grand Challenges in Neurotechnology and System Neuroergonomics
    Fairclough, Stephen H.
    Lotte, Fabien
    FRONTIERS IN NEUROERGONOMICS, 2020, 1
  • [45] Reengineering neurotechnology: placing patients first
    Markus Ploner
    Alena Buyx
    Jens Gempt
    Julijana Gjorgjieva
    Ruth Müller
    Josef Priller
    Daniel Rückert
    Bernhard Wolfrum
    Simon N. Jacob
    Nature Mental Health, 2023, 1 (1): : 5 - 7
  • [46] Perception as Media Reconsidering the Arts and Neurotechnology
    Rowland, Jess
    LEONARDO, 2021, 54 (04) : 406 - 411
  • [47] Review of Functional Cranioplasty and Implantable Neurotechnology
    Gordon, Chad R.
    Perez, Colleen F.
    JOURNAL OF CRANIOFACIAL SURGERY, 2025, 36 (02) : 387 - 393
  • [48] Of Man and Mice: Translational Research in Neurotechnology
    Stieglitz, Thomas
    NEURON, 2020, 105 (01) : 12 - 15
  • [49] Can neurotechnology revolutionize cognitive enhancement?
    Violante, Ines R.
    Okyere, Prince
    PLOS BIOLOGY, 2024, 22 (10)
  • [50] Neurotechnology: Current Developments and Ethical Issues
    Mueller, Oliver
    Rotter, Stefan
    FRONTIERS IN SYSTEMS NEUROSCIENCE, 2017, 11